-
Mashup Score: 3Stevens-Johnson Syndrome: A Case Series - Practical Dermatology - 11 month(s) ago
Successful treatment of drug-induced Stevens-Johnson Syndrome using cyclosporine and etanercept.
Source: Practical DermatologyCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 1The Concentration of Etanercept in Human Milk and Infant Outcomes - 11 month(s) ago
To the Editor: According to the National Institutes of Health, up to 23.5 million Americans (> 7% of the population) suffer from an autoimmune disease, and women are 2 times more likely to be diagnosed with an autoimmune disease than men.1,2 Medications such as etanercept (ETN) may be required for treatment of maternal disease during lactation. This can be problematic for lactating individuals…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Research Letter The Concentration of Etanercept in Human Milk and Infant Outcomes 📰 https://t.co/z1F63u1gPh #autoimmune #etanercept #lactation #infants https://t.co/A2dstMo2PA
-
-
Mashup Score: 0Etanercept Proves Safe, Long-Term Option for Treating Juvenile Idiopathic Arthritis - 11 month(s) ago
In addition to demonstrating efficacy, the numbers and incidence rates of treatment-emergent adverse events and treatment-emergent infections decreased throughout the 10-year follow-up.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In addition to demonstrating efficacy, the numbers and incidence rates of treatment-emergent adverse events & treatment-emergent infections decreased throughout the 10-year follow-up: https://t.co/QibeBfsE4j #Etanercept #PediatricRheumatology
-
-
Mashup Score: 0Etanercept Proves Safe, Long-Term Option for Treating Juvenile Idiopathic Arthritis - 11 month(s) ago
In addition to demonstrating efficacy, the numbers and incidence rates of treatment-emergent adverse events and treatment-emergent infections decreased throughout the 10-year follow-up.
Source: HCP LiveCategories: Latest Headlines, RheumatologyTweet-
In addition to demonstrating efficacy, the numbers and incidence rates of treatment-emergent adverse events and treatment-emergent infections decreased throughout the 10-year follow-up. #Etanercept #PediatricRheumatology https://t.co/Kj2lQR8nkJ https://t.co/K1FtxoOCqH
-
-
Mashup Score: 0
In patients with non-radiographic axial spondyloarthritis who achieved inactive disease with etanercept, approximately 25% remained flare-free at 40 weeks after ceasing treatment, according to data published in the Journal of Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
ICYMI: In patients with non-radiographic axial #spondyloarthritis who achieved inactive disease with #etanercept, approximately 25% remained flare-free at 40 weeks after ceasing treatment https://t.co/z5eacCqtJ6
-
-
Mashup Score: 0
In patients with non-radiographic axial spondyloarthritis who achieved inactive disease with etanercept, approximately 25% remained flare-free at 40 weeks after ceasing treatment, according to data published in the Journal of Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
In patients with non-radiographic axial #spondyloarthritis who achieved inactive disease with #etanercept, approximately 25% remained flare-free at 40 weeks after ceasing treatment https://t.co/z5eacCqtJ6
-
-
Mashup Score: 0Etanercept, adalimumab improve wellbeing in non-systemic juvenile idiopathic arthritis - 1 year(s) ago
Etanercept and adalimumab are both impactful at improving the health of patients with non-systemic juvenile idiopathic arthritis, according to data published in Pediatric Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
ICYMI: #Etanercept and #adalimumab are both impactful at improving the health of patients with non-systemic juvenile idiopathic arthritis #MedTwitter #ReumTwitter https://t.co/3Q7iNwYEnw
-
-
Mashup Score: 0Etanercept, adalimumab improve wellbeing in non-systemic juvenile idiopathic arthritis - 1 year(s) ago
Etanercept and adalimumab are both impactful at improving the health of patients with non-systemic juvenile idiopathic arthritis, according to data published in Pediatric Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
#Etanercept and #adalimumab are both impactful at improving the health of patients with non-systemic juvenile idiopathic arthritis #MedTwitter #ReumTwitter https://t.co/3Q7iNwYEnw
-
-
Mashup Score: 1
AbstractObjective. Biosimilars are approved as an alternative treatment to their originators. We compared the clinical outcomes of etanercept (ETN) biosimilar c
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
New on Advance Access: Real-world use of an #etanercept biosimilar in inflammatory arthritis, from @roxanne_cooksey et al. ⭐ Well-tolerated ⭐ Selective switch ➡ low failure rate ⭐ Auto switch ➡ slight worsening of disease 📖 https://t.co/7vPscDHADD Patient abstract 👇 https://t.co/g23BYtWnaF
-
-
Mashup Score: 3
Stevens-Johnson syndrome–toxic epidermal necrolysis (SJS-TEN) are fatal severe cutaneous adverse reactions, without consensus on the medical treatment. The use of systemic corticosteroids or intravenous immunoglobulin (IVIG) remains debatable. Tumor necrosis factor–alpha inhibitors are potentially effective.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Evaluation of #Combination #Therapy With #Etanercept and #Systemic #Corticosteroids for #Stevens- #Johnson #Syndrome and #Toxic #Epidermal #Necrolysis: A Multicenter Observational Study https://t.co/1vx45QGfPq https://t.co/F02dEN14uR
-
This issue's case series shares successful treatment of drug-induced #StevensJohnsonSyndrome using cyclosporine and #etanercept. https://t.co/bzn5E7K2BO https://t.co/3Vr3C6UG4x